vs

Side-by-side financial comparison of CRYO CELL INTERNATIONAL INC (CCEL) and TAYLOR DEVICES, INC. (TAYD). Click either name above to swap in a different company.

TAYLOR DEVICES, INC. is the larger business by last-quarter revenue ($11.6M vs $7.8M, roughly 1.5× CRYO CELL INTERNATIONAL INC). TAYLOR DEVICES, INC. runs the higher net margin — 17.3% vs -48.7%, a 66.0% gap on every dollar of revenue. On growth, TAYLOR DEVICES, INC. posted the faster year-over-year revenue change (35.7% vs -2.3%). TAYLOR DEVICES, INC. produced more free cash flow last quarter ($4.4M vs $1.2M). Over the past eight quarters, CRYO CELL INTERNATIONAL INC's revenue compounded faster (-0.1% CAGR vs -2.7%).

Cryo-Cell International, Inc. is a cord blood bank. It was founded by Dan Richard in 1989. Cryo-Cell International is the first private cord blood bank to separate and store stem cells. Cryo-Cell is headquartered outside of Tampa, in Oldsmar, Florida. In January 1997, the Company's stock began trading on the NASDAQ Small Cap market under symbol CCEL.

Taylor Corporation is a privately owned print and communications company headquartered in North Mankato, Minnesota, and was founded in 1975 by businessman Glen Taylor. The company comprises more than 90 locations and employs nearly 10,000 employees. Taylor has print operations in dozens of U.S. states and multiple countries around the world.

CCEL vs TAYD — Head-to-Head

Bigger by revenue
TAYD
TAYD
1.5× larger
TAYD
$11.6M
$7.8M
CCEL
Growing faster (revenue YoY)
TAYD
TAYD
+38.0% gap
TAYD
35.7%
-2.3%
CCEL
Higher net margin
TAYD
TAYD
66.0% more per $
TAYD
17.3%
-48.7%
CCEL
More free cash flow
TAYD
TAYD
$3.2M more FCF
TAYD
$4.4M
$1.2M
CCEL
Faster 2-yr revenue CAGR
CCEL
CCEL
Annualised
CCEL
-0.1%
-2.7%
TAYD

Income Statement — Q4 FY2025 vs Q2 FY2026

Metric
CCEL
CCEL
TAYD
TAYD
Revenue
$7.8M
$11.6M
Net Profit
$-3.8M
$2.0M
Gross Margin
77.9%
47.0%
Operating Margin
-50.6%
19.2%
Net Margin
-48.7%
17.3%
Revenue YoY
-2.3%
35.7%
Net Profit YoY
-105.1%
90.2%
EPS (diluted)
$-0.46

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CCEL
CCEL
TAYD
TAYD
Q4 25
$7.8M
$11.6M
Q3 25
$7.8M
$9.9M
Q2 25
$7.9M
$15.6M
Q1 25
$8.0M
$10.6M
Q4 24
$8.0M
$8.5M
Q3 24
$8.1M
$11.6M
Q2 24
$8.0M
$12.1M
Q1 24
$7.9M
$12.3M
Net Profit
CCEL
CCEL
TAYD
TAYD
Q4 25
$-3.8M
$2.0M
Q3 25
$749.4K
$2.2M
Q2 25
$355.8K
$3.7M
Q1 25
$282.9K
$2.0M
Q4 24
$-1.9M
$1.1M
Q3 24
$1.1M
$2.7M
Q2 24
$655.8K
$2.5M
Q1 24
$556.2K
$2.7M
Gross Margin
CCEL
CCEL
TAYD
TAYD
Q4 25
77.9%
47.0%
Q3 25
77.0%
44.8%
Q2 25
76.6%
48.6%
Q1 25
75.1%
42.9%
Q4 24
78.4%
45.5%
Q3 24
73.6%
47.4%
Q2 24
74.8%
48.8%
Q1 24
73.7%
46.9%
Operating Margin
CCEL
CCEL
TAYD
TAYD
Q4 25
-50.6%
19.2%
Q3 25
24.3%
22.6%
Q2 25
18.8%
24.2%
Q1 25
13.3%
19.1%
Q4 24
-1.5%
11.0%
Q3 24
17.2%
25.0%
Q2 24
17.3%
20.8%
Q1 24
10.5%
24.4%
Net Margin
CCEL
CCEL
TAYD
TAYD
Q4 25
-48.7%
17.3%
Q3 25
9.6%
22.1%
Q2 25
4.5%
23.7%
Q1 25
3.5%
19.0%
Q4 24
-23.2%
12.4%
Q3 24
13.0%
23.0%
Q2 24
8.2%
20.5%
Q1 24
7.1%
22.0%
EPS (diluted)
CCEL
CCEL
TAYD
TAYD
Q4 25
$-0.46
Q3 25
$0.09
Q2 25
$0.04
Q1 25
$0.03
Q4 24
$-0.23
Q3 24
$0.13
Q2 24
$0.08
Q1 24
$0.07

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CCEL
CCEL
TAYD
TAYD
Cash + ST InvestmentsLiquidity on hand
$3.3M
$40.7M
Total DebtLower is stronger
$8.4M
Stockholders' EquityBook value
$-18.6M
$67.1M
Total Assets
$61.7M
$72.8M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CCEL
CCEL
TAYD
TAYD
Q4 25
$3.3M
$40.7M
Q3 25
$3.2M
$36.3M
Q2 25
$4.4M
$36.0M
Q1 25
$3.5M
$35.4M
Q4 24
$3.5M
$26.6M
Q3 24
$2.1M
$27.1M
Q2 24
$1.5M
$31.0M
Q1 24
$979.6K
$24.6M
Total Debt
CCEL
CCEL
TAYD
TAYD
Q4 25
$8.4M
Q3 25
$8.4M
Q2 25
$8.4M
Q1 25
$8.5M
Q4 24
$8.5M
Q3 24
$8.5M
Q2 24
$8.5M
Q1 24
$8.6M
Stockholders' Equity
CCEL
CCEL
TAYD
TAYD
Q4 25
$-18.6M
$67.1M
Q3 25
$-14.8M
$64.3M
Q2 25
$-15.6M
$62.0M
Q1 25
$-14.7M
$57.8M
Q4 24
$-13.2M
$55.8M
Q3 24
$-9.6M
$53.9M
Q2 24
$-10.7M
$51.2M
Q1 24
$-10.3M
$47.8M
Total Assets
CCEL
CCEL
TAYD
TAYD
Q4 25
$61.7M
$72.8M
Q3 25
$63.2M
$70.3M
Q2 25
$64.4M
$71.6M
Q1 25
$64.4M
$70.1M
Q4 24
$64.7M
$62.9M
Q3 24
$62.9M
$61.9M
Q2 24
$62.6M
$63.1M
Q1 24
$61.7M
$54.8M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CCEL
CCEL
TAYD
TAYD
Operating Cash FlowLast quarter
$1.3M
$5.7M
Free Cash FlowOCF − Capex
$1.2M
$4.4M
FCF MarginFCF / Revenue
15.5%
38.3%
Capex IntensityCapex / Revenue
0.9%
11.3%
Cash ConversionOCF / Net Profit
2.86×
TTM Free Cash FlowTrailing 4 quarters
$5.2M
$14.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CCEL
CCEL
TAYD
TAYD
Q4 25
$1.3M
$5.7M
Q3 25
$2.5M
$483.6K
Q2 25
$707.0K
$1.9M
Q1 25
$954.1K
$9.0M
Q4 24
$2.2M
$103.1K
Q3 24
$2.4M
$-3.6M
Q2 24
$1.8M
$6.5M
Q1 24
$-356.9K
$-685.0K
Free Cash Flow
CCEL
CCEL
TAYD
TAYD
Q4 25
$1.2M
$4.4M
Q3 25
$2.5M
$298.6K
Q2 25
$644.6K
$491.3K
Q1 25
$892.0K
$8.8M
Q4 24
$2.1M
$-620.5K
Q3 24
$2.3M
$-3.8M
Q2 24
$21.5K
$6.1M
Q1 24
$-814.6K
$-895.5K
FCF Margin
CCEL
CCEL
TAYD
TAYD
Q4 25
15.5%
38.3%
Q3 25
31.9%
3.0%
Q2 25
8.1%
3.2%
Q1 25
11.2%
83.6%
Q4 24
26.8%
-7.3%
Q3 24
27.9%
-33.0%
Q2 24
0.3%
51.0%
Q1 24
-10.4%
-7.3%
Capex Intensity
CCEL
CCEL
TAYD
TAYD
Q4 25
0.9%
11.3%
Q3 25
0.5%
1.9%
Q2 25
0.8%
9.3%
Q1 25
0.8%
1.8%
Q4 24
0.1%
8.5%
Q3 24
2.3%
2.1%
Q2 24
21.8%
3.3%
Q1 24
5.8%
1.7%
Cash Conversion
CCEL
CCEL
TAYD
TAYD
Q4 25
2.86×
Q3 25
3.38×
0.22×
Q2 25
1.99×
0.52×
Q1 25
3.37×
4.51×
Q4 24
0.10×
Q3 24
2.32×
-1.35×
Q2 24
2.70×
2.65×
Q1 24
-0.64×
-0.25×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons